Kenneth Wils
Directeur/Membre du Conseil chez eTheRNA immunotherapies NV
Postes actifs de Kenneth Wils
Sociétés | Poste | Début | Fin |
---|---|---|---|
Participatiemaatschappij Vlaanderen NV
Participatiemaatschappij Vlaanderen NV Investment ManagersFinance Participatiemaatschappij Vlaanderen NV (PMV) is a private equity/venture capital firm, a subsidiary of Region of Flanders founded in 1995. Participatiemaatschappij Vlaanderen NV is headquartered in Brussels, Belgium. | Private Equity Investor | 01/01/2019 | - |
eTheRNA immunotherapies NV
eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Kenneth Wils
Anciens postes connus de Kenneth Wils
Sociétés | Poste | Début | Fin |
---|---|---|---|
Nutsbedrijven Houdstermaatschappij CVBA
Nutsbedrijven Houdstermaatschappij CVBA Financial ConglomeratesFinance Nutsbedrijven Houdstermaatschappij operates as a utilities holding company. The company is headquartered in Hasselt, Belgium. | Consultant / Advisor | 01/04/2018 | 01/12/2018 |
Foederer DFK
Foederer DFK Miscellaneous Commercial ServicesCommercial Services Foederer DFK provides accounting services. The private company is based in Hasselt, Belgium. | Consultant / Advisor | 01/06/2013 | 01/12/2018 |
Corporate Officer/Principal | 01/06/2013 | 01/12/2018 | |
Participatiemaatschappij Vlaanderen NV
Participatiemaatschappij Vlaanderen NV Investment ManagersFinance Participatiemaatschappij Vlaanderen NV (PMV) is a private equity/venture capital firm, a subsidiary of Region of Flanders founded in 1995. Participatiemaatschappij Vlaanderen NV is headquartered in Brussels, Belgium. | Private Equity Investor | 01/02/2007 | 01/05/2013 |
Fortis Bank (Nederland) NV (Broker) | Analyst-Equity | 30/11/2004 | 30/11/2004 |
Amakem NV
Amakem NV Medical/Nursing ServicesHealth Services Amakem NV operates as a biopharmaceutical company. It uses kinase inhibitors for treatments of bowel, eye, and lung diseases. The company was founded by Jack Elands, Dirk Leysen, Olivier Raynald Defert, and Nadya Kaval on July 22, 2009 and is headquartered in Diepenbeek, Belgium. | Directeur/Membre du Conseil | 15/02/2010 | - |
reMYND NV
reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | Directeur/Membre du Conseil | - | - |
TrendMiner NV
TrendMiner NV Data Processing ServicesTechnology Services TrendMiner NV provides data mining software and solutions. Its product TrendMiner delivers discovery, diagnostic and predictive analytics with real time monitoring tools for the process industry. The company was founded by Bart De Moor, Thomas Dhollander, Noel Jans, Bert Baeck, Tom Coen and Anthony Devney in December 2007 and is headquartered in Hasselt, Belgium. | Directeur/Membre du Conseil | 18/02/2010 | - |
Formation de Kenneth Wils
Katholieke Universiteit Leuven | Graduate Degree |
Vlerick Leuven Gent Management School | Masters Business Admin |
Statistiques
Internationale
Belgique | 10 |
Pays-Bas | 2 |
Opérationnelle
Director/Board Member | 4 |
Private Equity Investor | 2 |
Consultant / Advisor | 2 |
Sectorielle
Finance | 4 |
Commercial Services | 3 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 8 |
---|---|
Participatiemaatschappij Vlaanderen NV
Participatiemaatschappij Vlaanderen NV Investment ManagersFinance Participatiemaatschappij Vlaanderen NV (PMV) is a private equity/venture capital firm, a subsidiary of Region of Flanders founded in 1995. Participatiemaatschappij Vlaanderen NV is headquartered in Brussels, Belgium. | Finance |
TrendMiner NV
TrendMiner NV Data Processing ServicesTechnology Services TrendMiner NV provides data mining software and solutions. Its product TrendMiner delivers discovery, diagnostic and predictive analytics with real time monitoring tools for the process industry. The company was founded by Bart De Moor, Thomas Dhollander, Noel Jans, Bert Baeck, Tom Coen and Anthony Devney in December 2007 and is headquartered in Hasselt, Belgium. | Technology Services |
Fortis Bank (Nederland) NV (Broker) | Finance |
reMYND NV
reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | Commercial Services |
Nutsbedrijven Houdstermaatschappij CVBA
Nutsbedrijven Houdstermaatschappij CVBA Financial ConglomeratesFinance Nutsbedrijven Houdstermaatschappij operates as a utilities holding company. The company is headquartered in Hasselt, Belgium. | Finance |
Foederer DFK
Foederer DFK Miscellaneous Commercial ServicesCommercial Services Foederer DFK provides accounting services. The private company is based in Hasselt, Belgium. | Commercial Services |
Amakem NV
Amakem NV Medical/Nursing ServicesHealth Services Amakem NV operates as a biopharmaceutical company. It uses kinase inhibitors for treatments of bowel, eye, and lung diseases. The company was founded by Jack Elands, Dirk Leysen, Olivier Raynald Defert, and Nadya Kaval on July 22, 2009 and is headquartered in Diepenbeek, Belgium. | Health Services |
eTheRNA immunotherapies NV
eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | Health Technology |
- Bourse
- Insiders
- Kenneth Wils
- Expérience